| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | DCAKD |
| Uniprot No | Q8WVC6 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-231aa |
| 氨基酸序列 | MFLVGLTGGIASGKSSVIQVFQQLGCAVIDVDVMARHVVQPGYPAHRRIVEVFGTEVLLENGDINRKVLGDLIFNQPDRRQLLIAITHPEIRKEMMKETFKYFLRGYRYVILDIPLLFETKKLLKYMKHTVVVYCDRDTQLARLMRRNSLNRKDAEARINAQLPLTDKARMARHVLDNSGEWSVTKRQVILLHTELERSLEYLPLRFGVLTGLAAIASLLYLLTHYLLPYA |
| 分子量 | 52.9 kDa |
| 蛋白标签 | GST-tag at N-terminal |
| 缓冲液 | 0 |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于重组人DCAKD蛋白的示例性参考文献(假设该蛋白与代谢调控或疾病治疗相关)。**注：DCAKD蛋白名称可能需要进一步核实，以下内容为模拟文献摘要，供参考格式**：
---
1. **文献名称**：*Cloning, Expression, and Purification of Recombinant Human DCAKD Protein in Escherichia coli*
**作者**：Smith J, Lee R, et al.
**摘要**：本研究成功克隆了人源DCAKD基因，并通过大肠杆菌表达系统实现了重组蛋白的高效表达。采用镍柱亲和层析纯化，获得了高纯度的DCAKD蛋白，验证了其酶学活性，为后续功能研究奠定了基础。
2. **文献名称**：*Structural Analysis of DCAKD Reveals Key Residues for Substrate Binding*
**作者**：Zhang Y, Chen H, et al.
**摘要**：通过X射线晶体学解析了DCAKD蛋白的三维结构，发现其活性位点的关键氨基酸残基参与底物识别，为设计靶向DCAKD的小分子抑制剂提供了结构基础。
3. **文献名称**：*DCAKD as a Therapeutic Target in Cancer: Role in Metabolic Reprogramming*
**作者**：Wang L, Gupta S, et al.
**摘要**：研究证实DCAKD在肿瘤细胞代谢重编程中起重要作用。重组人DCAKD蛋白的体外实验表明，抑制其活性可减少乳酸生成并抑制肿瘤生长，提示其作为抗癌靶点的潜力。
4. **文献名称**：*Functional Characterization of DCAKD in Mitochondrial Enzyme Regulation*
**作者**：Kim M, Park T, et al.
**摘要**：利用重组DCAKD蛋白探究其与线粒体丙酮酸脱氢酶复合物的相互作用，发现DCAKD通过磷酸化调控该复合物活性，影响细胞能量代谢平衡。
---
**建议**：如需真实文献，请通过PubMed或Google Scholar检索"DCAKD"或相关关键词，并结合具体研究领域细化查询。
Recombinant human DCAKD protein is a genetically engineered form of the human DCAKD (Decarboxylase Domain-Containing Kinase Activity Protein D) expressed in heterologous systems like *E. coli* or mammalian cell lines. DCAKD, a conserved mitochondrial protein, plays a critical role in metabolic regulation by modulating pyruvate dehydrogenase kinase (PDK) activity, thereby influencing the pyruvate dehydrogenase complex (PDC) – a key gatekeeper of glucose oxidation. Structurally, it contains an N-terminal decarboxylase domain and a C-terminal kinase-like domain, though its precise catalytic mechanism remains under investigation.
Recombinant DCAKD is essential for studying its functional interactions, especially in energy metabolism and mitochondrial dysfunction. Dysregulation of DCAKD has been linked to metabolic disorders, neurodegenerative diseases, and cancer, making it a potential therapeutic target. The recombinant protein allows for high-purity, scalable production for biochemical assays, structural studies, and drug screening. Recent studies highlight its role in maintaining metabolic flexibility under stress conditions, suggesting relevance in diseases like diabetes or ischemia-reperfusion injury. By enabling precise manipulation in vitro and in vivo, recombinant DCAKD accelerates research into mitochondrial signaling pathways and candidate drug validation. Its development represents a crucial step toward understanding cellular bioenergetics and exploring novel treatments for metabolism-related pathologies.
×
